Johnson & Johnson Stock Rises Tuesday, Still Underperforms Market
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Johnson & Johnson (JNJ) inched 0.50% higher to $173.84 Tuesday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index rising 0.56% to 3,828.11 and the Dow Jones Industrial Average rising 1.02% to 33,160.83. This was the stock's fourth consecutive day of gains. Johnson & Johnson closed $12.85 below its 52-week high ($186.69), which the company reached on April 25th.
The stock underperformed when compared to some of its competitors Tuesday, as Roche Holding AG Part. Cert. rose 2.83% to $325.36, Merck & Co. Inc. (MRK) rose 1.43% to $101.50, and Pfizer Inc. (PFE) rose 0.55% to $47.35. Trading volume (5.1 M) remained 2.0 million below its 50-day average volume of 7.2 M.
Data source: Dow Jones Market Data, FactSet. Data compiled November 8, 2022.
(END) Dow Jones Newswires
November 08, 2022 16:33 ET (21:33 GMT)
Copyright (c) 2022 Dow Jones & Company, Inc.